APPLICATION
ANDA201071
TYPE
ANDA
ORIGINAL APPROVAL
2010-12-03
LATEST ACTION
2015-06-13
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
NIFEDIPINEDiscontinued
NIFEDIPINE 60MG · TABLET, EXTENDED RELEASE · ORAL
NIFEDIPINEDiscontinued
NIFEDIPINE 90MG · TABLET, EXTENDED RELEASE · ORAL
NIFEDIPINEDiscontinued
NIFEDIPINE 30MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2015-06-13Labeling · Supplement 5 · standardAP
2010-12-03OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.